Dong-E-E-Jiao Co Ltd is a China-based company engages in the manufacturing and selling of Chinese herb and traditional Chinese medicines, auxiliary materials for medicine, biological and healthcare products and genetically engineered medicines. The company also exports its products to Europe, the United States, and Southeast Asia.
1993
2.7K+
LTM Revenue $855M
LTM EBITDA $264M
$4.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dong-E-E-Jiao has a last 12-month revenue of $855M and a last 12-month EBITDA of $264M.
In the most recent fiscal year, Dong-E-E-Jiao achieved revenue of $816M and an EBITDA of $278M.
Dong-E-E-Jiao expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Dong-E-E-Jiao valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $650M | $816M | XXX | XXX | XXX |
Gross Profit | $380M | $456M | XXX | XXX | XXX |
Gross Margin | 59% | 56% | XXX | XXX | XXX |
EBITDA | $211M | $278M | XXX | XXX | XXX |
EBITDA Margin | 32% | 34% | XXX | XXX | XXX |
Net Profit | $107M | $159M | XXX | XXX | XXX |
Net Margin | 17% | 19% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dong-E-E-Jiao's stock price is CNY 61 (or $8).
Dong-E-E-Jiao has current market cap of CNY 39.5B (or $5.4B), and EV of CNY 31.0B (or $4.3B).
See Dong-E-E-Jiao trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$4.3B | $5.4B | XXX | XXX | XXX | XXX | $0.35 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dong-E-E-Jiao has market cap of $5.4B and EV of $4.3B.
Dong-E-E-Jiao's trades at 5.0x LTM EV/Revenue multiple, and 16.2x LTM EBITDA.
Analysts estimate Dong-E-E-Jiao's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dong-E-E-Jiao and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $4.3B | XXX | XXX | XXX |
EV/Revenue | 5.2x | XXX | XXX | XXX |
EV/EBITDA | 15.4x | XXX | XXX | XXX |
P/E | 25.4x | XXX | XXX | XXX |
P/E/Growth | 1.5x | XXX | XXX | XXX |
EV/FCF | 15.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDong-E-E-Jiao's NTM/LTM revenue growth is 16%
Dong-E-E-Jiao's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Dong-E-E-Jiao's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dong-E-E-Jiao's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dong-E-E-Jiao and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 26% | XXX | XXX | XXX | XXX |
EBITDA Margin | 34% | XXX | XXX | XXX | XXX |
EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 50% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 28% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
Opex to Revenue | 45% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dong-E-E-Jiao acquired XXX companies to date.
Last acquisition by Dong-E-E-Jiao was XXXXXXXX, XXXXX XXXXX XXXXXX . Dong-E-E-Jiao acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Dong-E-E-Jiao founded? | Dong-E-E-Jiao was founded in 1993. |
Where is Dong-E-E-Jiao headquartered? | Dong-E-E-Jiao is headquartered in China. |
How many employees does Dong-E-E-Jiao have? | As of today, Dong-E-E-Jiao has 2.7K+ employees. |
Is Dong-E-E-Jiao publicy listed? | Yes, Dong-E-E-Jiao is a public company listed on SHE. |
What is the stock symbol of Dong-E-E-Jiao? | Dong-E-E-Jiao trades under 000423 ticker. |
When did Dong-E-E-Jiao go public? | Dong-E-E-Jiao went public in 1996. |
Who are competitors of Dong-E-E-Jiao? | Similar companies to Dong-E-E-Jiao include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Dong-E-E-Jiao? | Dong-E-E-Jiao's current market cap is $5.4B |
What is the current revenue of Dong-E-E-Jiao? | Dong-E-E-Jiao's last 12-month revenue is $855M. |
What is the current EBITDA of Dong-E-E-Jiao? | Dong-E-E-Jiao's last 12-month EBITDA is $264M. |
What is the current EV/Revenue multiple of Dong-E-E-Jiao? | Current revenue multiple of Dong-E-E-Jiao is 5.0x. |
What is the current EV/EBITDA multiple of Dong-E-E-Jiao? | Current EBITDA multiple of Dong-E-E-Jiao is 16.2x. |
What is the current revenue growth of Dong-E-E-Jiao? | Dong-E-E-Jiao revenue growth between 2023 and 2024 was 26%. |
Is Dong-E-E-Jiao profitable? | Yes, Dong-E-E-Jiao is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.